Revenue: As of FY2026 Q2, the actual value is USD 5.295 B, beating the estimate of USD 5.259 B.

Preliminary Second Quarter 2026 Financial Results

For the second quarter ended June 30, 2026, GE HealthCare Technologies Inc. reported a year-over-year Revenue growth of 5.7%. Organic revenue growth was 3.5%. Total revenues for the three months ended June 30, 2026, were $5,295 million. Organic revenue stood at $5,182 million. GE HealthCare Technologies Inc. expects to report year-over-year growth in diluted EPS and Adjusted EPS, which is ahead of its prior expectation.

Operational Changes

On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare Technologies Inc. of his resignation as Chief Financial Officer, with his last day set for August 14, 2026. Following this, on July 23, 2026, George Newcomb, who serves as Controller and Chief Accounting Officer, was named interim Chief Financial Officer, effective August 14, 2026, and will continue his existing roles. GE HealthCare Technologies Inc. has initiated a search for a permanent successor for the CFO position.

Outlook / Guidance

GE HealthCare Technologies Inc. reaffirms its full-year 2026 guidance that was previously provided on April 29, 2026. The company will provide additional details regarding its complete second quarter results on July 29, 2026.